- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Concert Pharmaceuticals
Total 51372 results
-
M.D. Anderson Cancer CenterRegeneron PharmaceuticalsNot yet recruitingSMARCB1-Deficient MalignanciesUnited States
-
M.D. Anderson Cancer CenterSyndax PharmaceuticalsNot yet recruitingLeukemia | HOX GeneUnited States
-
Canadian Cancer Trials GroupJazz PharmaceuticalsRecruitingGastroesophageal AdenocarcinomaCanada
-
M.D. Anderson Cancer CenterRegeneron PharmaceuticalsRecruiting
-
Roswell Park Cancer InstituteJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Acute Myeloid Leukemia With Myelodysplasia-Related ChangesUnited States
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia | Myeloid NeoplasmUnited States
-
Dana-Farber Cancer InstituteRegeneron PharmaceuticalsActive, not recruitingAdvanced Cancer | Cutaneous Squamous Cell CarcinomaUnited States
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 | Myeloid NeoplasmUnited States
-
National Cancer Institute (NCI)Inovio PharmaceuticalsActive, not recruitingHepatitis C Infection | Chronic HepatitisUnited States, Puerto Rico
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsTerminatedNeuroma, Acoustic | Neurofibromatosis Type 2United States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedNeuroendocrine Carcinoma | Islet Cell CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterJazz PharmaceuticalsActive, not recruiting
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompleted
-
Pancreatic Cancer Action NetworkNovartis PharmaceuticalsActive, not recruitingMetastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Modra PharmaceuticalsThe Netherlands Cancer InstituteCompletedCastration-resistant Prostate CancerNetherlands
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsWithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | HLA-A*0201 Positive Cells Present | NY-ESO-1 Positive Tumor Cells PresentUnited States
-
M.D. Anderson Cancer CenterBellicum PharmaceuticalsTerminatedLeukemia | Myeloma | Myeloproliferative DiseasesUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelodysplastic SyndromeUnited States
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterAriad PharmaceuticalsWithdrawnLeukemia | FLT3-Mutated Acute Myeloid Leukemia | FLT3-Mutated High-Risk Myelodysplastic Syndrome
-
M.D. Anderson Cancer CenterOSI PharmaceuticalsTerminated
-
Regeneron PharmaceuticalsNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Hoosier Cancer Research NetworkNovartis PharmaceuticalsWithdrawnUrothelial Carcinoma
-
Scripps Clinic Cancer CenterThreshold PharmaceuticalsUnknownHepatocellular CarcinomaUnited States
-
Vion PharmaceuticalsUnknownLeukemiaFrance, United States, United Kingdom
-
Meyer PharmaceuticalsUnknownPancreatic CancerUnited States
-
LifeTime PharmaceuticalsUnknownMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Vion PharmaceuticalsCompleted
-
Inex PharmaceuticalsCompletedLymphomaUnited States, Canada
-
Vion PharmaceuticalsCompletedLeukemiaUnited States
-
Vion PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Vion PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Vion PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Vion PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States, France, United Kingdom
-
Daiichi PharmaceuticalsWithdrawnUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
BioCryst PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterOSI PharmaceuticalsWithdrawn
-
M.D. Anderson Cancer CenterLigand PharmaceuticalsCompletedAlopecia AreataUnited States
-
M.D. Anderson Cancer CenterVion PharmaceuticalsCompletedHematologic MalignanciesUnited States
-
ISA PharmaceuticalsRegeneron PharmaceuticalsActive, not recruitingSquamous Cell Carcinoma of the Oropharynx | HPV16 PositiveNetherlands, United States, United Kingdom, France, Belgium, Czechia, Spain, Italy, Germany, Brazil, Hungary, Mexico, Poland
-
Portola PharmaceuticalsCompleted
-
Portola PharmaceuticalsCompleted
-
Portola PharmaceuticalsCompletedHepatic ImpairmentUnited States
-
Portola PharmaceuticalsWithdrawn
-
Jazz PharmaceuticalsGW PharmaceuticalsCompletedSeizures | Tuberous Sclerosis ComplexUnited States
-
Solvay PharmaceuticalsUnimed PharmaceuticalsCompletedPrimary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)United States
-
Solvay PharmaceuticalsUnimed PharmaceuticalsCompletedPrimary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)United States
-
M.D. Anderson Cancer CenterRegeneron PharmaceuticalsNot yet recruiting
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsNot yet recruitingAcute Lymphoblastic Leukemia | Philadelphia Chromosome-PositiveUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsNot yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States